Greenlight Biosciences Holdings Pbc (GRNA) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access GRNA Annual Balance Sheets →
The balance sheet figures below highlight longer-term patterns in how Greenlight Biosciences Holdings Pbc finances operations and invests in assets.
Quarterly Report, GAAP in USD millions
ITEM
(Mar 31 2023)
(Dec 31 2022) (Sep 30 2022) (Jun 30 2022) (Mar 31 2022)
Assets
Cash & cash equivalent32.35
Cash & Short-term Investments32.00
Accounts receivable0.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current5.35
Total Current Assets37.70
Equipment/Property/Plant Net40.44
Long-term investments1.41
Other Assets, Noncurrent35.00
Total Assets113.69
Liabilities
Accounts Payable, Current AC1.07
Accrued Liabilities, Current AC11.48
Other Liabilities, Current18.59
Deferred Revenue, Current DE0.05
Total Current Liabilities31.19
Capital Lease and Other13.78
Total Long-term Debt13.78
Deferred Revenue, Noncurrent DE0.00
Other liabilities, Noncurrent46.78
Operating Lease Liability Current4.08
Warrant Liabilities0.02
Total Liabilities91.75
Stockholders' Equity
Common Stock Value0.02
Additional Paid In Capital Common Stock471.03
Retained Earnings / Accumulated Deficit-449.11
Other Equity0.00
Common Stockholder's Equity21.94
Total Stockholder's Equity21.94
Liabilities & Stockholder's Equity113.69
4 historic quarters locked

Sign in to unlock the full Greenlight Biosciences Holdings Pbc balance sheet history.

About Greenlight Biosciences Holdings Pbc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000950170-23-020835

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.